Abstract:BACKGROUND: Mammalian target of rapamycin (mTOR) is a central controller of cell growth, proliferation, metabolism, and angiogenesis. Thus, there is a great deal of interest in developing clinical drugs based on mTOR. In this paper, in silico models based on multi-scaffolds were developed to predict mTOR inhibitors or non-inhibitors. METHODS: First 1,264 diverse compounds were collected and categorized as mTOR inhibitors and non-inhibitors. Two methods, recursive partitioning (RP) and naïve Bayesian (NB), were used to build combinatorial classification models of mTOR inhibitors versus non-inhibitors using physicochemical descriptors, fingerprints, and atom center fragments (ACFs). RESULTS: A total of 253 models were constructed and the overall predictive accuracies of the best models were more than 90% for both the training set of 964 and the external test set of 300 diverse compounds. The scaffold hopping abilities of the best models were successfully evaluated through predicting 37 new recently published mTOR inhibitors. Compared with the best RP and Bayesian models, the classifier based on ACFs and Bayesian shows comparable or slightly better in performance and scaffold hopping abilities. A web server was developed based on the ACFs and Bayesian method (http://rcdd.sysu.edu.cn/mtor/). This web server can be used to predict whether a compound is an mTOR inhibitor or non-inhibitor online. CONCLUSION: In silico models were constructed to predict mTOR inhibitors using recursive partitioning and naïve Bayesian methods, and a web server (mTOR Predictor) was also developed based on the best model results. Compound prediction or virtual screening can be carried out through our web server. Moreover, the favorable and unfavorable fragments for mTOR inhibitors obtained from Bayesian classifiers will be helpful for lead optimization or the design of new mTOR inhibitors.

Prediction of Calmodulin Inhibitors

Study on COX Inhibitor Prediction Model Based on Machine Learning

The Computational Model to Predict Accurately Inhibitory Activity for Inhibitors Towardscyp3a4

Prediction of cytochrome P4502C9 inhibitors based on molecular indices

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Predicting Mtor Inhibitors with a Classifier Using Recursive Partitioning and Naïve Bayesian Approaches.

Pharmacophore model construction of beta-secretase inhibitors

Pharmacophore Model Construction of β-Secretase Inhibitors

Calcium Ion Binding to the Mutants of Calmodulin: A Structure-Based Computational Predictive Model of Binding Affinity Using a Charge Scaling Approach in Molecular Dynamics Simulation

Machine Learning Models for the Classification of CK2 Natural Products Inhibitors with Molecular Fingerprint Descriptors

Descriptor Selection Based on Variable Stability for Predicting Inhibitor Activity

In Silico Prediction of ROCK II Inhibitors by Different Classification Approaches

Activity Prediction of Angiotensin Converting Enzyme Inhibitors Based on the Quantitative Structure-Activity Relationship Method

In silico prediction of binding affinity for the androgen receptor ligands

Classification Models for Herg Potassium Channel Inhibitors Based on the Support Vector Machine Approach

Identification of potential CAMKK2 inhibitors based on virtual screening and molecular dynamics simulation

Establishment and evaluation of prediction models for the discovery of CYP1A2 inhibitors

Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approaches

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors

Prediction of Matrix Metal Proteinases-12 Inhibitors by Machine Learning Approaches.

Prediction of inhibition of matrix metalloproteinase inhibitors based on the combination of Projection Pursuit Regression and Grid Search method